Following a public comment period, the Federal Trade Commission has approved a final order designed to remedy the anticompetitive effects resulting from Abbott’s $8.3 billion acquisition of Alere.
WHAT:The Federal Trade Commission will host a workshop, “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics”. Acting FTC Chairman Maureen K. Ohlhausen and U.S. Food and Drug Commissioner Dr.
The Federal Trade Commission has filed an amicus brief jointly with the Department of Justice in the case of Chamber of Commerce v. City of Seattle, which is pending before the U.S. Court of Appeals for the Ninth Circuit.
The staff of the Federal Trade Commission has issued an opinion advising Crouse Health Hospital that an exemption under the Non-Profit Institutions Act, or NPIA, applied to its proposal to sell discounted pharmaceutical products to the employees and retirees, as well as their dependents, of its...
WHAT:The Federal Trade Commission will host a Roundtable, “The Effects of Occupational Licensure on Competition, Consumers, and the Workforce: Empirical Research and Results”. Acting Chairman Maureen K.
Red Ventures and Bankrate have agreed to a divestiture of Bankrate’s Caring.com business unit to settle Federal Trade Commission charges that their $1.4 billion merger would likely harm competition in the market for third-party paid referral service for senior living facilities.
The Federal Trade Commission has released its draft Strategic Plan for Fiscal Years 2018 to 2022 for public review and comment, as required under the GPRA Modernization Act of 2010, using guidance issued by the Office of Management and Budget. Every four years, government agencies are required to...
Red Ventures and Bankrate agreed to divest Bankrate’s Caring.com business unit to settle FTC charges that their $1.4 billion merger would likely harm competition in the market for third-party paid referral service for senior living facilities. According to a complaint filed by the FTC...
Federal Trade Commission staff has issued a public notice encouraging academic and industry research on the impact of certificates of public advantage (COPA) on prices, quality, access, and innovation for healthcare services.
The number of reverse-payment patent settlements entered into by pharmaceutical companies in fiscal year 2015 declined from fiscal year 2014, marking a second annual decrease in such settlements, according to a new FTC staff report.
The Federal Trade Commission testified today before the House Judiciary Subcommittee on Regulatory Reform, Commercial and Antitrust Law on the role of antitrust enforcement in the debate over network neutrality.
In an Initial Decision announced today, Chief Administrative Law Judge D. Michael Chappell upheld a Federal Trade Commission complaint against 1-800 Contacts, ruling that the agency has proved that the nation’s largest online retailer of contact lenses unlawfully orchestrated a web of...
Federal Trade Commission staff has submitted comments to Frank W. Berry, Commissioner of the Georgia Department of Community Health, supporting a Certificate of Need (CON) application filed by Lee County Medical Center.
The Federal Trade Commission’s Economic Liberty Task Force has announced the agenda for its second roundtable in Washington, DC on November 7, 2017, to examine empirical evidence on the effects of occupational licensing.
The Federal Trade Commission has announced an agenda for its upcoming workshop on competition issues related to prescription drug markets. The workshop, titled “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics,” will take place on November 8, 2017 at the FTC’s...
The Federal Trade Commission is seeking public comment on an application by Fresenius Medical Care AG & Co. KGaA to establish a new outpatient hemodialysis clinic.
The Federal Trade Commission will hold a workshop on November 8, 2017 entitled, “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics.” Acting FTC Chairman Maureen K. Ohlhausen and U.S. Food and Drug Commissioner Dr. Scott Gottlieb will give the keynote addresses.